Literature DB >> 14647960

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.

Leslie K Jacobsen1, W Einar Mencl, Kenneth R Pugh, Pawel Skudlarski, John H Krystal.   

Abstract

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is a potent and selective serotonin neurotoxin whose use is growing among adolescents. Although cognitive deficits among adult MDMA users are well documented, little is known of the cognitive and brain functional sequelae of MDMA use during adolescence.
OBJECTIVE: We tested for evidence of cognitive deficits and changes in brain function in a pilot sample of adolescent MDMA users, who were compared with adolescent non-users of MDMA.
METHODS: Selective and divided attention and verbal working memory were examined in six adolescent MDMA users and six non-users of MDMA who were similar in age, gender, IQ, and other substance use. Brain function was assessed during performance of the working memory task using functional magnetic resonance imaging (fMRI).
RESULTS: MDMA users had significantly prolonged reaction times during tests of selective and divided attention, and failed to deactivate the left hippocampus normally during high verbal working memory load.
CONCLUSIONS: MDMA use in adolescence may be associated with cognitive impairments and dysfunction of inhibitory circuits within the hippocampus. Further work is urgently needed to delineate the developmental impact and long-term functional and clinical significance of MDMA use during adolescence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14647960     DOI: 10.1007/s00213-003-1679-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

1.  GABA(B) receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity.

Authors:  V Varga; A Sik; T F Freund; B Kocsis
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

2.  Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state.

Authors:  P T Huerta; J E Lisman
Journal:  Nature       Date:  1993-08-19       Impact factor: 49.962

3.  Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain.

Authors:  C Köhler; H Steinbusch
Journal:  Neuroscience       Date:  1982-04       Impact factor: 3.590

4.  Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.

Authors:  Jörg Daumann; Bruno Fimm; Klaus Willmes; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Journal:  Brain Res Cogn Brain Res       Date:  2003-05

Review 5.  Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change.

Authors:  A C Parrott
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

6.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

7.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

8.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

9.  Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine.

Authors:  M A Wilson; G A Ricaurte; M E Molliver
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

Authors:  D M Stone; D C Stahl; G R Hanson; J W Gibb
Journal:  Eur J Pharmacol       Date:  1986-08-22       Impact factor: 4.432

View more
  29 in total

1.  MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Authors:  Giulia Costa; Nicola Simola; Micaela Morelli
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530

2.  The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe; Phillip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

3.  Brain activation during the Stroop task in adolescents with severe substance and conduct problems: A pilot study.

Authors:  Marie T Banich; Thomas J Crowley; Laetitia L Thompson; Benjamin L Jacobson; Xun Liu; Kristen M Raymond; Eric D Claus
Journal:  Drug Alcohol Depend       Date:  2007-05-11       Impact factor: 4.492

4.  Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Authors:  John Karageorgiou; Mary S Dietrich; Evonne J Charboneau; Neil D Woodward; Jennifer U Blackford; Ronald M Salomon; Ronald L Cowan
Journal:  Neuroimage       Date:  2009-03-02       Impact factor: 6.556

Review 5.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

Review 6.  Neurobiology of adolescent substance use disorders: implications for prevention and treatment.

Authors:  Helena J V Rutherford; Linda C Mayes; Marc N Potenza
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-07

7.  Neuroimaging in human MDMA (Ecstasy) users.

Authors:  Ronald L Cowan; Deanne M Roberts; James M Joers
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Authors:  Tristan J Watkins; Vidya Raj; Junghee Lee; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Ronald M Salomon; Sohee Park; Margaret M Benningfield; Christina R Di Iorio; Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

9.  Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.

Authors:  Benjamin Becker; Daniel Wagner; Philip Koester; Katja Bender; Christoph Kabbasch; Euphrosyne Gouzoulis-Mayfrank; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2012-09-23       Impact factor: 4.530

10.  Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.

Authors:  Cynthia A Crawford; Michael T Williams; Jodie L Kohutek; Fiona Y Choi; Shelly T Yoshida; Sanders A McDougall; Charles V Vorhees
Journal:  Brain Res       Date:  2006-02-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.